Not sure about that. A private payer fully on board would be material. Private payers are probably a big part of the re-imbuirsement strategy to help depth of sales. Just saying,
Prove me wrong please - I am happy for he MSB Wiki to tell me that US private payers have laready agreed to re-imsburse treatment with Rnyocil...
Countdown to Interim Analysis, page-153
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
-0.105(8.05%) |
Mkt cap ! $1.364B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.30 | $1.17 | $12.26M | 9.967M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 38602 | $1.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 31698 | 14 |
View Market Depth
| Last trade - 12.11pm 24/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |